Literature DB >> 22401822

Gold nanoparticles-decorated silicon nanowires as highly efficient near-infrared hyperthermia agents for cancer cells destruction.

Yuanyuan Su1, Xinpan Wei, Fei Peng, Yiling Zhong, Yimei Lu, Shao Su, Tingting Xu, Shuit-Tong Lee, Yao He.   

Abstract

Near-infrared (NIR) hyperthermia agents are of current interest because they hold great promise as highly efficacious tools for cancer photothermal therapy. Although various agents have been reported, a practical NIR hyperthermia agent is yet unavailable. Here, we present the first demonstration that silicon nanomaterials-based NIR hyperthermia agent, that is, gold nanoparticles-decorated silicon nanowires (AuNPs@SiNWs), is capable of high-efficiency destruction of cancer cells. AuNPs@SiNWs are found to possess strong optical absorbance in the NIR spectral window, producing sufficient heat under NIR irradiation. AuNPs@SiNWs are explored as novel NIR hyperthermia agents for photothermal ablation of tumor cells. In particular, three different cancer cells treated with AuNPs@SiNWs were completely destructed within 3 min of NIR irradiation, demonstrating the exciting potential of AuNPs@SiNWs for NIR hyperthermia agents.
© 2012 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22401822     DOI: 10.1021/nl204203t

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  16 in total

1.  Dual-enhanced photothermal conversion properties of reduced graphene oxide-coated gold superparticles for light-triggered acoustic and thermal theranostics.

Authors:  Li-Sen Lin; Xiangyu Yang; Gang Niu; Jibin Song; Huang-Hao Yang; Xiaoyuan Chen
Journal:  Nanoscale       Date:  2016-01-28       Impact factor: 7.790

2.  In situ growth of fluorescent silicon nanocrystals in a monolithic microcapsule as a photostable, versatile platform.

Authors:  Guixian Zhu; Yu Huang; Gauri Bhave; Yuzhen Wang; Zhongbo Hu; Xuewu Liu
Journal:  Nanoscale       Date:  2016-08-25       Impact factor: 7.790

3.  Double-effector nanoparticles: a synergistic approach to apoptotic hyperthermia.

Authors:  Dongwon Yoo; Heeyeong Jeong; Christian Preihs; Jin-sil Choi; Tae-Hyun Shin; Jonathan L Sessler; Jinwoo Cheon
Journal:  Angew Chem Int Ed Engl       Date:  2012-11-08       Impact factor: 15.336

4.  Cuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondria.

Authors:  Y Wang; F Yang; H X Zhang; X Y Zi; X H Pan; F Chen; W D Luo; J X Li; H Y Zhu; Y P Hu
Journal:  Cell Death Dis       Date:  2013-08-29       Impact factor: 8.469

5.  Programming cancer through phase-functionalized silicon based biomaterials.

Authors:  Priyatha Premnath; Krishnan Venkatakrishnan; Bo Tan
Journal:  Sci Rep       Date:  2015-06-04       Impact factor: 4.379

6.  Promoting cell proliferation using water dispersible germanium nanowires.

Authors:  Michael Bezuidenhout; Pai Liu; Shalini Singh; Maeve Kiely; Kevin M Ryan; Patrick A Kiely
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

7.  A new bifunctional hybrid nanostructure as an active platform for photothermal therapy and MR imaging.

Authors:  Mona Khafaji; Manouchehr Vossoughi; M Reza Hormozi-Nezhad; Rassoul Dinarvand; Felix Börrnert; Azam Irajizad
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

8.  Cuprous oxide nanoparticles inhibit the growth of cervical carcinoma by inducing autophagy.

Authors:  Leilei Xia; Ye Wang; Ya Chen; Jiuqiong Yan; Fan Hao; Xiaoling Su; Caihong Zhang; Mingjuan Xu
Journal:  Oncotarget       Date:  2017-05-15

9.  Cuprous oxide nanoparticle-inhibited melanoma progress by targeting melanoma stem cells.

Authors:  Bin Yu; Ye Wang; Xinlu Yu; Hongxia Zhang; Ji Zhu; Chen Wang; Fei Chen; Changcheng Liu; Jingqiang Wang; Haiying Zhu
Journal:  Int J Nanomedicine       Date:  2017-04-05

Review 10.  Nanoparticles for imaging: top or flop?

Authors:  Fabian Kiessling; Marianne E Mertens; Jan Grimm; Twan Lammers
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.